1-4 of 4
Kensei Tobinai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of Inotuzumab Ozogamicin Combined with R-CVP for Relapsed/Refractory CD22+ B-cell Non-Hodgkin Lymphoma

Free
Michinori Ogura, Kensei Tobinai, Kiyohiko Hatake, Andrew Davies, Michael Crump, Revathi Ananthakrishnan, Taro Ishibashi, M. Luisa Paccagnella, Joseph Boni, Erik Vandendries, David MacDonald
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (19): 4807–4816.
https://doi.org/10.1158/1078-0432.CCR-15-2488
Published: 02 October 2016
View articletitled, Phase I Study of Inotuzumab Ozogamicin Combined with R-CVP for Relapsed/Refractory CD22+ B-cell Non-Hodgkin Lymphoma
Open the PDF for Phase I Study of Inotuzumab Ozogamicin Combined with R-CVP for Relapsed/Refractory CD22+ B-cell Non-Hodgkin Lymphoma in another window
Includes: Supplementary data
Journal Articles

Putting the Clinical and Biological Heterogeneity of Non-Hodgkin Lymphoma into Context

Free
Owen A. O'Connor, Kensei Tobinai
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (20): 5173–5181.
https://doi.org/10.1158/1078-0432.CCR-14-0574
Published: 14 October 2014
View articletitled, Putting the Clinical and Biological Heterogeneity of Non-Hodgkin Lymphoma into Context
Open the PDF for Putting the Clinical and Biological Heterogeneity of Non-Hodgkin Lymphoma into Context in another window
Journal Articles

Human T-cell Lymphotropic Virus Type I–Associated Adult T-cell Leukemia–Lymphoma: New Directions in Clinical Research

Free
Kunihiro Tsukasaki, Kensei Tobinai
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (20): 5217–5225.
https://doi.org/10.1158/1078-0432.CCR-14-0572
Published: 14 October 2014
View articletitled, Human T-cell Lymphotropic Virus Type I–Associated Adult T-cell Leukemia–Lymphoma: New Directions in Clinical Research
Open the PDF for Human T-cell Lymphotropic Virus Type I–Associated Adult T-cell Leukemia–Lymphoma: New Directions in Clinical Research in another window
Journal Articles

Therapeutic Potential of a Reduced-Intensity Preparative Regimen for Allogeneic Transplantation with Cladribine, Busulfan, and Antithymocyte Globulin against Advanced/Refractory Acute Leukemia/Lymphoma

Free
Takeshi Saito, Yoshinobu Kanda, Masahiro Kami, Kazunori Kato, Nahoko Shoji, Sachiyo Kanai, Toshihiro Ohnishi, Yoshifumi Kawano, Kunihisa Nakai, Toshie Ogasawara, Hiroshi Matsubara, Atsushi Makimoto, Ryuji Tanosaki, Kensei Tobinai, Hiro Wakasugi, Yoichi Takaue, Shin Mineishi
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 1014–1020.
Published: 01 April 2002
View articletitled, Therapeutic Potential of a Reduced-Intensity Preparative Regimen for Allogeneic Transplantation with Cladribine, Busulfan, and Antithymocyte Globulin against Advanced/Refractory Acute Leukemia/Lymphoma
Open the PDF for Therapeutic Potential of a Reduced-Intensity Preparative Regimen for Allogeneic Transplantation with Cladribine, Busulfan, and Antithymocyte Globulin against Advanced/Refractory Acute Leukemia/Lymphoma in another window